Balance Sheet Dive: Gossamer Bio Inc (GOSS)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $0.74 in the prior trading day, Gossamer Bio Inc (NASDAQ: GOSS) closed at $0.72, down -2.70%. In other words, the price has decreased by -$2.70 from its previous closing price. On the day, 0.6 million shares were traded. GOSS stock price reached its highest trading level at $0.75 during the session, while it also had its lowest trading level at $0.7201.

Ratios:

Our goal is to gain a better understanding of GOSS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.74 and its Current Ratio is at 6.74. In the meantime, Its Debt-to-Equity ratio is 3.76 whereas as Long-Term Debt/Eq ratio is at 3.73.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on June 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $9.

UBS Downgraded its Buy to Neutral on July 27, 2023, whereas the target price for the stock was revised from $8 to $1.25.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 24 ’24 when Aranda Richard sold 1,908 shares for $0.66 per share. The transaction valued at 1,260 led to the insider holds 196,891 shares of the business.

Hasnain Faheem bought 372,000 shares of GOSS for $250,282 on Jun 21 ’24. The President & CEO now owns 5,408,073 shares after completing the transaction at $0.67 per share. On Jun 18 ’24, another insider, Giraudo Bryan, who serves as the COO/CFO of the company, bought 100,000 shares for $0.59 each. As a result, the insider paid 59,110 and bolstered with 480,010 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GOSS now has a Market Capitalization of 163177536 and an Enterprise Value of 39769640. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.49 while its Price-to-Book (P/B) ratio in mrq is 3.01. Its current Enterprise Value per Revenue stands at 0.378 whereas that against EBITDA is -0.644.

Stock Price History:

The Beta on a monthly basis for GOSS is 1.91, which has changed by -0.026315808 over the last 52 weeks, in comparison to a change of 0.2936039 over the same period for the S&P500. Over the past 52 weeks, GOSS has reached a high of $1.60, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is -22.43%, while the 200-Day Moving Average is calculated to be -23.22%.

Shares Statistics:

The stock has traded on average 859.70K shares per day over the past 3-months and 1082150 shares per day over the last 10 days, according to various share statistics. A total of 225.41M shares are outstanding, with a floating share count of 173.94M. Insiders hold about 23.24% of the company’s shares, while institutions hold 62.87% stake in the company. Shares short for GOSS as of 1730332800 were 6304348 with a Short Ratio of 7.33, compared to 1727654400 on 7752737. Therefore, it implies a Short% of Shares Outstanding of 6304348 and a Short% of Float of 2.87.

Most Popular